Trial Profile

A first-in-human phase 1 study of KB 9558 in multiple myeloma

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 04 Sep 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

04 Sep 2024 According to a Kronos Bio media release, the company will present oral presentation at the International Myeloma Society (IMS) 21st Annual Meeting, taking place September 25 - 28, 2024 in Rio de Janeiro, Brazil.
21 Mar 2024 According to a Kronos Bio media release, IND-enabling studies for KB-9558 expected to complete in 2024 with first-in-human study anticipated to commence and expect to dose first patients in the first half of 2025.
12 Mar 2024 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com